Results 101 to 110 of about 12,611 (222)

Proportion (%) of HCV positive PWID (antibody or RNA) undiagnosed.

, 2014
Proportion (%) of HCV positive PWID (antibody or RNA) undiagnosed.
Bart Grady (605397), Catharina Matheï (605402), Peter Vickerman (210007), Marica Ferri (605396), Vivian D. Hope (605401), Lucas Wiessing (483360), Katelyn J. Cullen (605400), Maria Prins (339491), Maria Kantzanou (605398), Ida Sperle (605399), Angelos Hatzakis (146074), Jeffrey V. Lazarus (250583)   +11 more
core   +1 more source

Incidence of HCV infection in PWID (per 100 person years).

, 2014
Incidence of HCV infection in PWID (per 100 person years).
Bart Grady (605397), Catharina Matheï (605402), Peter Vickerman (210007), Marica Ferri (605396), Vivian D. Hope (605401), Lucas Wiessing (483360), Katelyn J. Cullen (605400), Maria Prins (339491), Maria Kantzanou (605398), Ida Sperle (605399), Angelos Hatzakis (146074), Jeffrey V. Lazarus (250583)   +11 more
core   +1 more source

Health-associated quality of life impairment in people who inject drugs (PWID) after bloodstream infection [PDF]

BACKGROUND: People who inject drugs (PWID) have high rates of bloodstream infections (BSI) with Staphylococcus aureus (SA) and group A streptococcus (GAS). Little is known about health-related quality of life outcomes after BSI.
Plevneshi, E, Mortimer, I, Lillie, P J, Barlow, G, Burns, P, Easom, N, Richards, A   +6 more
core   +1 more source

Depressive symptoms and determinants among people who inject drugs in Kaduna State, Nigeria

African Journal of Primary Health Care & Family Medicine
Background: People who inject drugs (PWID) are known to have higher rates of mental health disorders, particularly depression. Despite this, there is a lack of research on the prevalence of depression among PWID in Nigeria.
Nuhu N. Butawa, Awawu G. Nmadu, Sunday Audu, Fidelis O. Ajuonuma, Khadeejah L. Hamza, Sunday Joseph, Abdullateef G. Sule, Joel Adze, Victoria N. Omole, Moroof O. Suleman, Suleiman Usman   +10 more
doaj   +1 more source

Prevalence and associated risk factors of current hepatitis C infection among U.S. general population and injection drug users aged 20-59 years: NHANES 2009-2018.

PLoS ONE
IntroductionThe people who inject drugs (PWID) are attributed to high-risk groups for transmission of the Hepatitis C virus (HCV). This study assessed the prevalence and associated factors of current HCV infection (CHI) among U.S.
Harun Mazumder, Md Faruk Hossain, Pratibha Shrestha, Sultan Mahmud, Maidul Husain, Rebeka Ahmed   +5 more
doaj   +1 more source

Hepatitis C virus micro‐elimination in people who inject drugs: Challenges and chance in Taiwan and worldwide

Kaohsiung Journal of Medical Sciences
With the introduction of direct‐acting antivirals, elimination of hepatitis C virus (HCV) infection is becoming possible. People who inject drugs (PWID) represent a population with a high risk for HCV infection, which has been reported as high as 90% in ...
Chi‐Ming Tai, Ming‐Lung Yu
doaj   +1 more source

Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct-acting antiviral therapy

Frontiers in Immunology
BackgroundHepatitis C virus (HCV) infections are more prevalent in people who inject drugs (PWID) who often experience additional health risks. HCV induces inflammation and immune alterations that contribute to hepatic and non-hepatic morbidities.
Anna C. Hearps, Anna C. Hearps, Nikil Vootukuru, Nikil Vootukuru, Salimeh Ebrahimnezhaddarzi, Brendan L. Harney, Brendan L. Harney, Brendan L. Harney, Irene Boo, Long Nguyen, Damian Pavlyshyn, Paul M. Dietze, Paul M. Dietze, Heidi E. Drummer, Heidi E. Drummer, Heidi E. Drummer, Alexander J. Thompson, Anthony Jaworowski, Anthony Jaworowski, Margaret E. Hellard, Margaret E. Hellard, Margaret E. Hellard, Margaret E. Hellard, Margaret E. Hellard, Rachel Sacks-Davis, Rachel Sacks-Davis, Rachel Sacks-Davis, Joseph S. Doyle, Joseph S. Doyle   +28 more
doaj   +1 more source

Achieving HIV epidemic control through accelerating efforts to expand access to pre-exposure prophylaxis for people who inject drugs

Frontiers in Reproductive Health
The world is not on track to reach the majority of the UNAIDS 2025 targets, and people who inject drugs (PWID) continue to be left behind, hindered by counterproductive law enforcement practices, punitive laws, economic distress, and social stigma and ...
Lirica Nishimoto, Adaobi Lisa Olisa, Philip Imohi, Judy Chang, Chris Obermeyer, Dama Kabwali, Christopher Akolo   +6 more
doaj   +1 more source

Reimagining Hepatitis C Elimination: Time for Actions, Not Targets

Journal of the International AIDS Society, Volume 29, Issue 8, August 2026.
Marina B. Klein, Nadine Kronfli, Jim Young   +2 more
wiley   +1 more source

High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique

BMC Infectious Diseases, 2019
Background Few countries in sub-Saharan Africa know the magnitude of their HIV epidemic among people who inject drugs (PWID). This was the first study in Mozambique to measure prevalence of HIV, HBV, and HCV, and to assess demographic characteristics and
Cynthia Semá Baltazar, Roberta Horth, Makini Boothe, Isabel Sathane, Peter Young, Denise Chitsondzo Langa, Manuel Condula, Helena Ricardo, Liliana Dengo Baloi, Beverley Cummings, Nicolas Schaad, Lídia Gouveia, Eugénia Teodoro, Henry F. Raymond   +13 more
doaj   +1 more source